Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
Go back to Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.01 -0.01 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $7.79 | |||
| Open | $2.03 | 52 Week Low | $4.32 | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $1.99 | EPS | $-0.36 | |||
| Volume | 124,405 | |||||
